Literature DB >> 437247

The relationship of diphenyleneiodonium-induced hypoglycaemia to the specific covalent modification of NADH-ubiquinone oxidoreductase.

D P Bloxham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 437247     DOI： 10.1042/bst0070103

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN： 0300-5127            Impact factor:   5.407


× No keyword cloud information.
  7 in total

1.  The effect of the inhibitor diphenylene iodonium on the superoxide-generating system of neutrophils. Specific labelling of a component polypeptide of the oxidase.

Authors:  A R Cross; O T Jones
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

2.  The inhibition by diphenyleneiodonium and its analogues of superoxide generation by macrophages.

Authors:  J T Hancock; O T Jones
Journal:  Biochem J       Date:  1987-02-15       Impact factor: 3.857

Review 3.  NADPH oxidase enzymes in skin fibrosis: molecular targets and therapeutic agents.

Authors:  Olubukola Babalola; Andrew Mamalis; Hadar Lev-Tov; Jared Jagdeo
Journal:  Arch Dermatol Res       Date:  2013-10-24       Impact factor: 3.017

4.  Experimentally induced defects of mitochondrial metabolism in rat skeletal muscle. Biological effects of the NADH: coenzyme Q reductase inhibitor diphenyleneiodonium.

Authors:  D J Hayes; E Byrne; E A Shoubridge; J A Morgan-Hughes; J B Clark
Journal:  Biochem J       Date:  1985-07-01       Impact factor: 3.857

5.  A precision therapeutic strategy for hexokinase 1-null, hexokinase 2-positive cancers.

Authors:  Shili Xu; Arthur Catapang; Daniel Braas; Linsey Stiles; Hanna M Doh; Jason T Lee; Thomas G Graeber; Robert Damoiseaux; Orian Shirihai; Harvey R Herschman
Journal:  Cancer Metab       Date:  2018-06-28

Review 6.  NOX enzymes as novel targets for drug development.

Authors:  J David Lambeth; Karl-Heinz Krause; Robert A Clark
Journal:  Semin Immunopathol       Date:  2008-05-29       Impact factor: 11.759

7.  Hypervalent Iodine(III) Compounds as Biaxial Halogen Bond Donors.

Authors:  Flemming Heinen; Elric Engelage; Christopher J Cramer; Stefan M Huber
Journal:  J Am Chem Soc       Date:  2020-04-29       Impact factor: 15.419
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.